Correlation Between NovaBay Pharmaceuticals and Tenax Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and Tenax Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and Tenax Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and Tenax Therapeutics, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and Tenax Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of Tenax Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and Tenax Therapeutics.

Diversification Opportunities for NovaBay Pharmaceuticals and Tenax Therapeutics

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between NovaBay and Tenax is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and Tenax Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenax Therapeutics and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with Tenax Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenax Therapeutics has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and Tenax Therapeutics go up and down completely randomly.

Pair Corralation between NovaBay Pharmaceuticals and Tenax Therapeutics

Considering the 90-day investment horizon NovaBay Pharmaceuticals is expected to under-perform the Tenax Therapeutics. In addition to that, NovaBay Pharmaceuticals is 1.22 times more volatile than Tenax Therapeutics. It trades about -0.3 of its total potential returns per unit of risk. Tenax Therapeutics is currently generating about -0.28 per unit of volatility. If you would invest  640.00  in Tenax Therapeutics on January 11, 2025 and sell it today you would lose (105.00) from holding Tenax Therapeutics or give up 16.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NovaBay Pharmaceuticals  vs.  Tenax Therapeutics

 Performance 
       Timeline  
NovaBay Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NovaBay Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Tenax Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tenax Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

NovaBay Pharmaceuticals and Tenax Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NovaBay Pharmaceuticals and Tenax Therapeutics

The main advantage of trading using opposite NovaBay Pharmaceuticals and Tenax Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, Tenax Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenax Therapeutics will offset losses from the drop in Tenax Therapeutics' long position.
The idea behind NovaBay Pharmaceuticals and Tenax Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope